bpc 157 safety human trials BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157 – No Proof Required!
Description
Dig Liver Dis 36:337341
Current pharmaceutical design, 17 (16), 16121632
To ensure clarity, the focus of this discussion is primarily on autism and its association with folate receptor autoantibodies, while acknowledging that other neurological disorders, such as epilepsy and Parkinsons disease, may have related metabolic issues but are not necessarily linked directly to folate autoimmunity
I cant get it to go down
